Page 83 - JCTR-11-5
P. 83

Journal of Clinical and
            Translational Research                                          Fibromyalgia: Examination across life domains



               doi: 10.33448/rsd-v11i4.27704                      of  predominant  neuropathic,  nociceptive  and  central
                                                                  sensitization pain. Acta Oncol. 2016;55(6):659-663.
            29.  Ramos  F,  Hora  A,  Souza C.  Contributions  of social
               epidemiology to clinical research on infectious diseases.      doi: 10.3109/0284186X.2016.1167958
               Pan-Amazonian Journal of Health. 2016;7:221-229.
                                                               41.  Macfarlane G, Kronisch C, Dean L, et al. EULAR revised
               doi: 10.5123/s2176-62232016000500025               recommendations for the management of fibromyalgia. Ann
                                                                  Rheum Dis. 2017;76(2):318-328.
            30.  Souza HR, Providello M, Faustini RK, Silva VF, Abreu J.
               Epidemiological profile of women with Fibromyalgia in the      doi: 10.1136/annrheumdis-2016-209724
               far north of Espírito Santo. Rev CEREUS. 2023;15(4):13-24
                                                               42.  Clauw D, D’Arcy Y, Gebke K, Semel D, Pauer L, Jones KD.
            31.  Zimmer Z, Chayovan N, Lin H, Natividad J. How indicators   Normalizing fibromyalgia as a chronic illness. Postgrad Med.
               of socioeconomic status relate to physical functioning   2018;130(1):9-18.
               of older adults in three Asian Societies.  Res Aging.
               2004;26(2):224-258.                                doi: 10.1080/00325481.2018.1411743
                                                               43.  Edwards RR, Dworkin RH, Sullivan MD, Turk DC,
               doi: 10.1177/0164027503260624
                                                                  Wasan  AD. The  role  of  psychosocial processes  in the
            32.  Gaskin DJ, Richard P. The economic costs of pain in the   development and maintenance of chronic pain.  J  Pain.
               United States. J Pain. 2012;13(8):715-724.         2016;17(9):T70-T92.
               doi: 10.1016/j.jpain.2012.03.009                   doi: 10.1016/j.jpain.2016.01.001
            33.  Alberti F, Blatt C, Pilger D. Direct and indirect costs   44.  Arnold L, Bennett R, Crofford LJ, et al. AAPT diagnostic
               of fibromyalgia: a scoping review.  J Bras Econ Saúde.   criteria for fibromyalgia. J Pain. 2019;20(6):611-628.
               2021;13(3):338-344.
                                                                  doi: 10.1016/j.jpain.2018.10.008
               doi: 10.21115/JBES.v13.n3.p338-44
                                                               45.  Rodríguez-Almagro D, López-Ruiz M, Cortés-Pérez I,
            34.  Muñoz  R,  Silva  A, Dantas D,  Fernandes  A.  Therapeutic   Obrero-Gaitan E, Lomas-Veja R. Optimal dose and type of
               itineraries of people with fibromyalgia to a pain treatment   exercise to reduce pain, anxiety and increase quality of life in
               center: A qualitative study. ABCS Health Sci. 2018;43(3):148-  patients with fibromyalgia. A systematic review with meta-
               155.                                               analysis. Front Physiol. 2023;14:1170621.
               doi: 10.7322/abcshs.v43i3.1087                     doi: 10.3389/fphys.2023.1170621
            35.  Schaefer C, Adams E, Udall M, et al. Fibromyalgia outcomes   46.  Mascarenhas R, Souza M, Oliveira M, et al. Association of
               over time: Results from a prospective observational study in   therapies with reduced pain and improved quality of life in
               the United States. Open Rheumatol J. 2016;10:109-121.  patients with fibromyalgia: A systematic review and meta-
               doi: 10.2174/1874312901610010109                   analysis. JAMA Intern Med. 2021;181(1):104-112.
            36.  Fernandes  R,  Morais  N,  Viebig  RF,  Morimoto  JM.      doi: 10.1001/JAMAINTERNMED.2020.5651
               Relationship between sleep disorders and fibromyalgia   47.  Ghavidel-Parsa B, Bidari A, Maafi A, Ghalebaghi B. The
               severity: the impact on quality of life of Brazilian users of   Iceberg nature of fibromyalgia burden: The clinical and
               social networks. Rev Bras Qual Vida. 2020;12(1).   economic aspects. Korean J Pain. 2015;28(3):169-176.
               doi: 10.3895/rbqv.v12n1.10150                      doi: 10.3344/kjp.2015.28.3.169
            37.  Gerdle B, Ghafouri B, Ernberg M, Larsson B. Chronic   48.  Borsook D, Youssef AM, Simons L, Elman I, Eccleston C.
               musculoskeletal pain: Review of mechanisms and     When pain gets stuck: The evolution of pain chronification
               biochemical  biomarkers as  assessed by the  microdialysis   and treatment resistance. Pain. 2018;159(12):2421-2436.
               technique. J Pain Res. 2014;7:313-326.
                                                                  doi: 10.1097/j.pain.0000000000001401
               doi: 10.2147/JPR.S59144
                                                               49.  Bergsten L, Lundberg M, Lindberg P, Elfving B. Change in
            38.  Häuser W, Fitzcharles MA. Facts and myths pertaining to   kinesiophobia and its relation to activity limitation after
               fibromyalgia. Dialogues Clin Neurosci. 2018;20(1):53-62.  multidisciplinary rehabilitation in patients with chronic
               doi: 10.31887/DCNS.2018.20.1/whauser               back pain. Disabil Rehabil. 2012;34(10):852-858.
            39.  Martínez-Lavín M. Fibromyalgia and small fiber neuropathy:      doi: 10.3109/09638288.2011.624247
               The plot thickens! Clin Rheumatol. 2018;37(12):3167-3171.
                                                               50.  Vlaeyen J, Linton S. Fear-avoidance model of chronic
               doi: 10.1007/s10067-018-4300-2                     musculoskeletal  pain:  12  years  on.  Pain.  2012;153(6):
                                                                  1144-1147.
            40.  Nijs J, Leysen L, Adriaenssens N,  et al. Pain following
               cancer treatment: Guidelines for the clinical classification      doi: 10.1016/j.pain.2011.12.009


            Volume 11 Issue 5 (2025)                        77                         doi: 10.36922/JCTR025290042
   78   79   80   81   82   83   84   85   86   87   88